Yfat K, Mariam K, Mario B, Hal H, et al. Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer. Gynecol Oncol 2022 Sep 22. pii: S0090-8258(22)00574.
PMID: 36154762